These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 23275532)

  • 21. Overexpression of
    Falco A; Aranaga C; Ocampo I; Takiff H
    Int J Microbiol; 2021; 2021():6689186. PubMed ID: 33824663
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A systematic review of gyrase mutations associated with fluoroquinolone-resistant Mycobacterium tuberculosis and a proposed gyrase numbering system.
    Maruri F; Sterling TR; Kaiga AW; Blackman A; van der Heijden YF; Mayer C; Cambau E; Aubry A
    J Antimicrob Chemother; 2012 Apr; 67(4):819-31. PubMed ID: 22279180
    [TBL] [Abstract][Full Text] [Related]  

  • 23. DNA gyrase inhibition assays are necessary to demonstrate fluoroquinolone resistance secondary to gyrB mutations in Mycobacterium tuberculosis.
    Pantel A; Petrella S; Matrat S; Brossier F; Bastian S; Reitter D; Jarlier V; Mayer C; Aubry A
    Antimicrob Agents Chemother; 2011 Oct; 55(10):4524-9. PubMed ID: 21768507
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A Series of Spiropyrimidinetriones that Enhances DNA Cleavage Mediated by
    Byl JAW; Mueller R; Bax B; Basarab GS; Chibale K; Osheroff N
    ACS Infect Dis; 2023 Mar; 9(3):706-715. PubMed ID: 36802491
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antimycobacterial activities of novel fluoroquinolones.
    Senthilkumar P; Dinakaran M; Yogeeswari P; China A; Nagaraja V; Sriram D
    Biomed Pharmacother; 2009 Jan; 63(1):27-35. PubMed ID: 18031974
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Molecular Genetics of Fluoroquinolone Resistance in Mycobacterium tuberculosis.
    Mayer C; Takiff H
    Microbiol Spectr; 2014 Aug; 2(4):MGM2-0009-2013. PubMed ID: 26104201
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Moonlighting function of glutamate racemase from Mycobacterium tuberculosis: racemization and DNA gyrase inhibition are two independent activities of the enzyme.
    Sengupta S; Ghosh S; Nagaraja V
    Microbiology (Reading); 2008 Sep; 154(Pt 9):2796-2803. PubMed ID: 18757813
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dual targeting of topoisomerase IV and gyrase to reduce mutant selection: direct testing of the paradigm by using WCK-1734, a new fluoroquinolone, and ciprofloxacin.
    Strahilevitz J; Hooper DC
    Antimicrob Agents Chemother; 2005 May; 49(5):1949-56. PubMed ID: 15855518
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sensitivities of ciprofloxacin-resistant Mycobacterium tuberculosis clinical isolates to fluoroquinolones: role of mutant DNA gyrase subunits in drug resistance.
    Suzuki Y; Nakajima C; Tamaru A; Kim H; Matsuba T; Saito H
    Int J Antimicrob Agents; 2012 May; 39(5):435-9. PubMed ID: 22421328
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of antimycobacterial and DNA gyrase inhibition of fluoroquinolone derivatives.
    Sriram D; Bal TR; Yogeeswari P; Radha DR; Nagaraja V
    J Gen Appl Microbiol; 2006 Aug; 52(4):195-200. PubMed ID: 17116967
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Revelation of point mutations effect in Mycobacterium tuberculosis MfpA protein that involved in mycobacterial DNA supercoiling and fluoroquinolone resistance.
    Gautam P; Shivangi ; Meena LS
    Biotechnol Appl Biochem; 2020 Oct; ():. PubMed ID: 33095938
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mechanism of binding of fluoroquinolones to the quinolone resistance-determining region of DNA gyrase: towards an understanding of the molecular basis of quinolone resistance.
    Madurga S; Sánchez-Céspedes J; Belda I; Vila J; Giralt E
    Chembiochem; 2008 Sep; 9(13):2081-6. PubMed ID: 18677735
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gyrase mutations in laboratory-selected, fluoroquinolone-resistant mutants of Mycobacterium tuberculosis H37Ra.
    Kocagöz T; Hackbarth CJ; Unsal I; Rosenberg EY; Nikaido H; Chambers HF
    Antimicrob Agents Chemother; 1996 Aug; 40(8):1768-74. PubMed ID: 8843279
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular Characterization of Mycobacterium ulcerans DNA Gyrase and Identification of Mutations Reducing Susceptibility to Quinolones
    Kim H; Mori S; Kenri T; Suzuki Y
    Antimicrob Agents Chemother; 2022 Apr; 66(4):e0190221. PubMed ID: 35041504
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interaction of the plasmid-encoded quinolone resistance protein Qnr with Escherichia coli DNA gyrase.
    Tran JH; Jacoby GA; Hooper DC
    Antimicrob Agents Chemother; 2005 Jan; 49(1):118-25. PubMed ID: 15616284
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dynamics of fluoroquinolones induced resistance in DNA gyrase of Mycobacterium tuberculosis.
    Pandey B; Grover S; Tyagi C; Goyal S; Jamal S; Singh A; Kaur J; Grover A
    J Biomol Struct Dyn; 2018 Feb; 36(2):362-375. PubMed ID: 28071975
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Global Regulatory Cyclic AMP Receptor Protein (CRP) Controls Multifactorial Fluoroquinolone Susceptibility in Salmonella enterica Serovar Typhimurium.
    Kary SC; Yoneda JRK; Olshefsky SC; Stewart LA; West SB; Cameron ADS
    Antimicrob Agents Chemother; 2017 Nov; 61(11):. PubMed ID: 28874380
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Functional analysis of DNA gyrase mutant enzymes carrying mutations at position 88 in the A subunit found in clinical strains of Mycobacterium tuberculosis resistant to fluoroquinolones.
    Matrat S; Veziris N; Mayer C; Jarlier V; Truffot-Pernot C; Camuset J; Bouvet E; Cambau E; Aubry A
    Antimicrob Agents Chemother; 2006 Dec; 50(12):4170-3. PubMed ID: 17015625
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of Neisseria gonorrhoeae Type II Topoisomerases by the Novel Spiropyrimidinetrione AZD0914.
    Kern G; Palmer T; Ehmann DE; Shapiro AB; Andrews B; Basarab GS; Doig P; Fan J; Gao N; Mills SD; Mueller J; Sriram S; Thresher J; Walkup GK
    J Biol Chem; 2015 Aug; 290(34):20984-20994. PubMed ID: 26149691
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Crystal structure and stability of gyrase-fluoroquinolone cleaved complexes from Mycobacterium tuberculosis.
    Blower TR; Williamson BH; Kerns RJ; Berger JM
    Proc Natl Acad Sci U S A; 2016 Feb; 113(7):1706-13. PubMed ID: 26792525
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.